Showing results (931-940 of 2,522) with videos related to
Sort By:
Pageof 253
Inflammopharmacology|November 18, 2021
Ouabain inhibits p38 activation in mice neutrophilsLuiz Henrique Agra Cavalcante-Silva, Deyse Cristina Madruga Carvalho, Éssia de Almeida Lima, et al.Inflammopharmacology|November 18, 2021
Deubiquitylating enzymes: potential target in autoimmune diseasesNiraj Parihar, Lokesh Kumar BhattInflammopharmacology|November 4, 2022
Effects of Quinoa (Chenopodium quinoa) on inflammatory mediators: a systematic review of preclinical studiesAida Malek Mahdavi, Zeinab Javadivala, Yeganeh Khalili, et al.Inflammopharmacology|September 16, 2022
Potential role of lipoxin in the management of COVID-19: a narrative reviewGaber El-Saber Batiha, Ali I Al-Gareeb, Engy Elekhnawy, et al.Inflammopharmacology|September 1, 2022
Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)Banlambhabok Khongthaw, Kanika Dulta, Pankaj Kumar Chauhan, et al.Inflammopharmacology|January 15, 2022
Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritisKane Langdon, Geraldine Buitrago, Darren Pickering, et al.Inflammopharmacology|September 28, 2021
Diabetic neovascularization defects in the retina are improved by genistein supplementation in the ovariectomized ratHadi Yousefi, Alireza Komaki, Siamak Shahidi, et al.Inflammopharmacology|February 24, 2022
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialSepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.Inflammopharmacology|October 6, 2021
Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategiesMohammad Salemizadeh Parizi, Fatemeh Salemizadeh Parizi, Saeed Abdolhosseini, et al.Inflammopharmacology|February 15, 2022
Effect of statins on the plasma/serum levels of inflammatory markers in patients with cardiovascular disease; a systematic review and meta-analysis of randomized clinical trialsMitra Abbasifard, Tahmineh Kandelouei, Saeed Aslani, et al.Pageof 253